• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Platelets Stored for 6 to 7 Days Are Not Inferior to Platelets Stored for 2 to 5 Days for Stable Hematology Patients

August 14, 2015

Bacteria research

Bacterial contamination is a major concern for platelets, which limits platelet storage and availability. Platelets are currently stored at room temperature for up to 5 days.

The National Health Service Blood and Transplant of the United Kingdom recently conducted a randomized non-inferiority trial comparing platelets stored for 2- to 5-days versus 6- to 7-days in 122 adult thrombocytopenic hematology patients. After bacterial screening, researchers found no evidence that platelets stored for 2- to 5-days were superior to platelets stored for 6- to 7-days in stable hematology patients.  Seventy-one percent of transfusions with platelets stored 2- to 5-days (mean=3.8 days, SD=1.0) were successful compared to 69% of transfusions for platelets stored 6- to 7-days (mean=6.4 days, SD=0.5)).  The mean corrected platelet count increments, the number of bleeding events, and the interval to the next transfusions were comparable in each group.  Further research is needed to evaluate platelets stored for up to 7 days used for transfusions in trauma and surgery patients.

Reference

  1. MacLennan S, Harding K, Llewelyn C, Choo L, Bakrania L, Massey E, Stanworth S, Pendry K, Williamson LM.  A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2- to 5- versus 6- or 7-day stored platelets.  Transfusion 2015;55: 1856–1865.

TRF_CMETransfusion offers CME credit for this study! Log on at www.wileyhealthlearning.com/trf.

Filed Under

  • CME
  • News
  • Platelet Transfusion
  • Quality Control and Regulatory

Recommended

  • Patients with Hematologic Cancers Have Lower Rates of Alloimmunization with RhD

  • Motivators and Barriers to Donating Blood Among African Americans

  • Minimal Residual Risk for HIV, Hepatitis B, and Hepatitis C from Blood Products

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

  • New Guidelines for Platelet Transfusion Recommend Restrictive Strategies

  • Directed Blood Donations Should be Limited

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley